Home » Topics » Regulatory » Patents

Patents
RSS

Chloride channel blockers useful for sickle cell anemia

Feb. 23, 1998

Novel NK1 antagonists described by Merck & Co.

Feb. 23, 1998

Abbott reveals new motilides

Feb. 23, 1998

PKC inhibitors described by Lilly

Feb. 23, 1998

PKC inhibitors under study at Hoechst Marion Roussel

Feb. 20, 1998

Selective dopamine D3 ligands described by P&U

Feb. 20, 1998

Allergan's new antiglaucoma agents

Feb. 20, 1998

Neurocrine Biosciences describes compounds for increasing endogenous neuropeptide levels

Feb. 20, 1998

Warner-Lambert reveals new antipsychotic benzoxazinones

Feb. 20, 1998

Oxcarbazepine derivatives with potent anticonvulsant activity

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.